Prognostic models for selecting patients with acute pulmonary embolism for initial outpatient therapy

Chest

Volumn 132, Issue 1, 2007, Pages 24-30

  Jiménez, David ^a,j   Yusen, Roper D ^b   Otero, Remedios ^c   Uresandi, Fernando ^d   Nauffal, Dolores ^e   Laserna, Elena ^c   Conget, Francisco ^f   Oribe, Mikel ^g   Cabezudo, Miguel A ^h   Díaze, Gema ⁱ  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^d HOSPITAL DE CRUCES   (Spain)

^e HOSPITAL UNIVERSITARIO LA FE   (Spain)

^f Lozano Blesa Hospital   (Spain)

^g HOSPITAL DE GALDAKAO   (Spain)

^h Oviedo Hospital   (Spain)

ⁱ Hospital de la Zarzuela   (Spain)

^j UNIVERSITY OF ALCALÁ   (Spain)

more..

Author keywords

Prognosis; Pulmonary embolism; Score

Indexed keywords

ACENOCOUMAROL; ANTIVITAMIN K; ENOXAPARIN; HEPARIN;

ADULT; AGED; ARTICLE; BLEEDING; CONTROLLED STUDY; FEMALE; GENEVA SCORE; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MODEL; MORTALITY; OUTPATIENT CARE; PATIENT SELECTION; PERFORMANCE; PRIORITY JOURNAL; PROGNOSIS; PULMONARY EMBOLISM SEVERITY INDEX; RECURRENT DISEASE; RISK ASSESSMENT; SCORING SYSTEM;

EID: 34447520617     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.06-2921     Document Type: Article

References (24)

1. Levine M, Gent M, Hirsh J, et al. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med 1996; 334: 677-681
2. Koopman M, Prandoni P, Piovella F, et al. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. N Engl J Med 1996; 334:682-687
3. Wells PS, Kovacs MJ, Bormanis J, et al. Expanding eligibility for outpatient treatment of deep venous thrombosis and pulmonary embolism with low-molecular-weight heparin. Arch Intern Med 1998; 158:1809-1812
4. Yusen RD, Gage BF. Outpatient treatment of acute venous thromboembolic disease. Clin Chest Med 2003; 24:49-61
5. Wicki J, Perrier A, Perneger TV, et al. Predicting adverse outcome in patients with acute pulmonary embolism: a risk score. Thromb Haemost 2000; 84:548-552
6. Nendaz MR, Bandelier P, Aujesky D, et al. Validation of a risk score identifying patients with acute pulmonary embolism, who are at low risk of clinical adverse outcome. Thromb Haemost 2004; 91:1232-1236
7. Aujesky D, Obrosky DS, Stone RA, et al. Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med 2005; 172:1041-1046
8. Aujesky D, Roy PM, Le Manach CP, et al. Validation of a model to predict adverse outcomes in patients with pulmonary embolism. Eur Heart J 2006; 27:476-481
9. PIOPED Investigators. Value of ventilation/perfusion scan in acute pulmonary embolism: results of the prospective investigation of the pulmonary embolism diagnosis (PIOPED). JAMA 1990; 263: 2753-2759
10. Turkstra F, Kiujer PM, van Beek E, et al. Diagnostic utility of ultrasonography of leg veins in patients suspected of having pulmonary embolism. Ann Intern Med 1997; 126:775-781
11. Remy-Jardin M, Remy J, Wattinne L, et al. Central pulmonary thromboembolism: diagnosis with spiral volumetric CT with the single-breath-hold-technique-comparison with pulmonary angiography. Radiology 1992; 185:381-387
12. Prandoni P, Cogo A, Bernardi E, et al. A simple approach for detection of recurrent proximal vein thrombosis. Circulation 1993; 88:1730-1735
13. Goldhaber SZ, Visana L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999; 353:1386-1389
14. Zidane M, van Hulsteijn LH, Brenninkmeijer BJ, et al. Out of hospital treatment with subcutaneous low molecular weight heparin in patients with acute deep-vein thrombosis: a prospective study in daily practice. Haematologica 2006; 91: 1052-1058
15. Beer JH, Burger M, Gretener S, et al. Outpatient treatment of pulmonary embolism is feasible and safe in a substantial proportion of patients. J Thromb Haemost 2003; 1:186-187
16. Kovacs MJ, Anderson D, Morrow B, et al. Outpatient treatment of pulmonary embolism with dalteparin. Thromb Haemost 2000; 83:209-211
17. Lim AY, Parr DG, Stableforth DE, et al. Early discharge and home supervision of patients with pulmonary embolism treated with low-molecular weight heparin. Eur J Intern Med 2003; 14:89-93
18. Aujesky D, Smith KJ, Cornuz J, et al. Cost-effectiveness of low-molecular-weight heparin for treatment of pulmonary embolism. Chest 2005; 128:1601-1610
19. Konstantinides S, Geibel A, Olschewski M, et al. Importance of cardiac troponin in risk stratification of patients with acute pulmonary embolism. Circulation 2002; 106:1263-1268
20. Douketis JD, Leewenkamp O, Grobara P, et al. The incidence and prognostic significance of elevated cardiac troponin in patients with submassive pulmonary embolism. J Thromb Haemost 2005; 3:508-513
21. Binder L, Pieske B, Olschewski M, et al. N-terminal probrain natriuretic peptide or troponin testing followed by echocardiography for risk stratification of acute pulmonary embolism. Circulation 2005; 112:1573-1579
22. Krüger S, Graf J, Merx MW, et al. Brain natriuretic peptide predicts right heart failure in patients with acute pulmonary embolism. Am Heart J 2004; 147:60-65
23. Goldhaber SZ. Thrombolytic therapy for patients with pulmonary embolism who are hemodynamically stable but have right ventricular dysfunction. Arch Intern Med 2005; 165:2197-2199
24. Ghuysen A, Ghaye B, Willems V, et al. Computed tomographic pulmonary angiography and prognostic significance in patients with acute pulmonary embolism. Thorax 2005; 60:956-961